Veracyte (VCYT) Operating Income (2012 - 2026)

Veracyte (VCYT) has 15 years of Operating Income data on file, last reported at $22.6 million in Q1 2026.

• Quarterly Operating Income rose 679.82% year-over-year to $22.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.5 million (up 227.06% YoY) and the FY2025 annual result came in at $57.8 million, up 257.93% from the prior year.
• Operating Income slipped to $22.6 million in Q1 2026 per VCYT's latest filing, from $37.2 million in the prior quarter.
• The five-year high for Operating Income was $37.2 million in Q4 2025, with the low at -$35.5 million in Q4 2023.
• Average Operating Income over 5 years is -$1.8 million, with a median of -$5.3 million recorded in 2025.
• Year-over-year, Operating Income tumbled 555.11% in 2023 and jumped 790.9% in 2025.
• Veracyte's Operating Income stood at -$5.4 million in 2022, then plunged by 555.11% to -$35.5 million in 2023, then jumped by 111.76% to $4.2 million in 2024, then jumped by 790.9% to $37.2 million in 2025, then slumped by 39.12% to $22.6 million in 2026.
• Business Quant data shows VCYT's Operating Income at $22.6 million in Q1 2026, $37.2 million in Q4 2025, and $22.9 million in Q3 2025.